文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

基于常规收集数据和动态治疗方案确定急性肾损伤透析时机

Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes.
PubMed 文献 · Crit Care · 2022-11-28
一句话结论一项因果分析提示,将RRT推迟至钾≥7 mmol/L、持续少尿24–36 h和/或pH<7.0(非少尿)或<7.2(少尿)可降低30天ICU死亡率,但该方案为假设生成性,作者认为需多中心RCT验证。

该研究在比利时根特大学医院ICU的常规收集数据中,纳入KDIGO-AKI≥2期患者,应用逆概率删失加权Aalen-Johansen估计量,比较81种基于时间更新钾、pH和尿量的动态治疗方案对30天ICU死亡率的影响。结果显示,将RRT推迟至钾≥7 mmol/L、持续少尿24–36 h和/或pH<7.0(非少尿)或<7.2(少尿)的方案使30天ICU死亡率从12.7%降至10.5%(风险差2.2% [95%CI 1.3–3.8%]),且未增加RRT启动人数。最优DTR的五折交叉验证基准30天ICU死亡率为10.7%。作者认为当前多数RCT采用的RRT启动标准可能非最优,但该分析为假设生成性,最优DTR理想情况下需在多中心RCT中验证。

要点

  • 在KDIGO-AKI≥2期ICU患者中,将RRT推迟至钾≥7 mmol/L、持续少尿24–36 h和/或pH<7.0(非少尿)或<7.2(少尿)的DTR使30天ICU死亡率从12.7%降至10.5%,风险差2.2%(95%CI 1.3–3.8%)。
  • 该推迟RRT的DTR未增加启动RRT的患者数(从471例 [95%CI 430–511] 至475例 [95%CI 342–572])。
  • 最优DTR的五折交叉验证基准30天ICU死亡率为10.7%。
  • 作者认为,当前多数RCT采用的RRT启动标准可能非最优;但该分析为假设生成性,最优DTR理想情况下需在多中心RCT中验证。

适用人群与场景

  • 在根特大学医院ICU住院、符合KDIGO-AKI≥2期的患者被纳入。
  • 共13,403例符合条件患者(60.8 ± 16.8岁,SOFA 7.0 ± 4.1),其中5,622例(63.4 ± 15.3岁,SOFA 8.2 ± 4.2)符合KDIGO-AKI≥2期。

诊断标准与关键阈值

  • KDIGO-AKI分期≥2期。
  • 动态治疗方案(DTR)依据时间更新的钾、pH和尿量水平预设阈值。
  • 最优DTR的阈值:钾≥7 mmol/L、持续少尿24–36 h、和/或pH<7.0(非少尿)或<7.2(少尿),且经最大保守治疗。

处置流程与药物剂量

  • 最优DTR:在最大保守治疗下,将RRT推迟至钾≥7 mmol/L、持续少尿24–36 h和/或pH<7.0(非少尿)或<7.2(少尿)时启动。

研究设计与关键结果

  • 研究设计:基于常规收集数据的因果分析,应用逆概率删失加权Aalen-Johansen估计量,比较81种DTR对30天ICU死亡率的影响。
  • 主要结果:最优DTR使30天ICU死亡率从当前标准治疗的12.7%(95%CI 11.9–13.6%)降至10.5%(95%CI 9.5–11.7%),风险差2.2%(95%CI 1.3–3.8%)。
  • 启动RRT人数:从471例(95%CI 430–511)至475例(95%CI 342–572),无增加。
  • 五折交叉验证:最优DTR的30天ICU死亡率为10.7%。

证据类型、等级与局限

  • 证据类型:基于常规收集数据的因果分析(观察性研究)。
  • 局限:作者指出该分析为假设生成性,最优DTR理想情况下需在多中心RCT中验证。

对床旁实践的改变

  • 作者认为,当前多数RCT采用的RRT启动标准可能非最优。
  • 作者认为,所识别的推迟RRT的DTR可降低30天ICU死亡率且不增加RRT启动人数,但该分析为假设生成性,最优DTR理想情况下需在多中心RCT中验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVES: Defining the optimal moment to start renal replacement therapy (RRT) in acute kidney injury (AKI) remains challenging. Multiple randomized controlled trials (RCTs) addressed this question whilst using absolute criteria such as pH or serum potassium. However, there is a need for identification of the most optimal cut-offs of these criteria. We conducted a causal analysis on routinely collected data (RCD) to compare the impact of different pre-specified dynamic treatment regimes (DTRs) for RRT initiation based on time-updated levels of potassium, pH, and urinary output on 30-day ICU mortality.

DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: Patients in the ICU of Ghent University Hospital were included at the time they met KDIGO-AKI-stage ≥ 2. We applied inverse-probability-of-censoring-weighted Aalen-Johansen estimators to evaluate 30-day survival under 81 DTRs prescribing RRT initiation under different thresholds of potassium, pH, or persisting oliguria.

RESULTS: Out of 13,403 eligible patients (60.8 ± 16.8 years, SOFA 7.0 ± 4.1), 5622 (63.4 ± 15.3 years, SOFA 8.2 ± 4.2) met KDIGO-AKI-stage ≥ 2. The DTR that delayed RRT until potassium ≥ 7 mmol/l, persisting oliguria for 24-36 h, and/or pH < 7.0 (non-oliguric) or < 7.2 (oliguric) despite maximal conservative treatment resulted in a reduced 30-day ICU mortality (from 12.7% [95% CI 11.9-13.6%] under current standard of care to 10.5% [95% CI 9.5-11.7%]; risk difference 2.2% [95% CI 1.3-3.8%]) with no increase in patients starting RRT (from 471 [95% CI 430-511] to 475 [95% CI 342-572]). The fivefold cross-validation benchmark for the optimal DTR resulted in 30-day ICU mortality of 10.7%.

CONCLUSIONS: Our causal analysis of RCD to compare RRT initiation at different thresholds of refractory low pH, high potassium, and persisting oliguria identified a DTR that resulted in a decrease in 30-day ICU mortality without increase in number of RRTs. Our results suggest that the current criteria to start RRT as implemented in most RCTs may be suboptimal. However, as our analysis is hypothesis generating, this optimal DTR should ideally be validated in a multicentric RCT.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Morzywołek P, Steen J, Vansteelandt S, et al. Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes. Crit Care. 2022. PMID: 36443861. doi:10.1186/s13054-022-04252-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。